Meet The Team
Sean holds a PhD in immuno-pharmacology from the University of Liverpool, focused on developing experimental and conceptual means to address T-cell mediated hypersensitivity reactions. He has long-standing links with drug safety research at Liverpool where he received the Syngenta prize for Pharmacology at degree level and where he maintains an academic profile. He has several publications focused on the immuno-toxicological aspects of small molecular weight compounds and immune-checkpoint inhibitors. Sean particularly values working with inter-disciplinary experts to drive rational, data-led decision making in drug development projects.
Read more about Dr Sean Hammond